Evidence map›Paper›PMID 38720081›Full record

ArticleNature2024

Boron catalysis in a designer enzyme.

Lars Longwitz, Reuben B Leveson-Gower, Henriëtte J Rozeboom, Andy-Mark W H Thunnissen, Gerard Roelfes

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Reprogramming NAD(P)Angewandte Chemie (International ed. in English) · 2026
    Article
  5. Article
  6. Exploring PadR Proteins for Artificial Enzyme Design.Chembiochem : a European journal of chemical biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lars Longwitz *Stratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-2525-4678
Reuben B Leveson-Gower *Stratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-7254-3950
Henriëtte J RozeboomGroningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands.
Andy-Mark W H ThunnissenGroningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-1915-9850
Gerard RoelfesStratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands. j.g.roelfes@rug.nl.ORCID 0000-0002-0364-9564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes play an increasingly important role in improving the benignity and efficiency of chemical production, yet the diversity of their applications lags heavily behind chemical catalysts as a result of the relatively narrow range of reaction mechanisms of enzymes. The creation of enzymes containing non-biological functionalities facilitates reaction mechanisms outside nature's canon and paves the way towards fully programmable biocatalysis

Indexed as

BiocatalysisBoronic AcidsEnzymesProtein EngineeringCrystallography, X-RayDirected Molecular EvolutionKetonesKineticsMass SpectrometryModels, MolecularNuclear Magnetic Resonance, BiomolecularOximesSubstrate SpecificityXenobioticsBoronic AcidsEnzymesKetonesOximesXenobiotics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.